Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Am J Transplant. 2012 Dec 27;13(2):299–311. doi: 10.1111/ajt.12016

Table 3.

rPSGL-1 therapy reduces CD45+ cell infiltration in donor specific MHC I antibody-treated allografts.

Group Treatment Hearts with
CD45
score ≥2
%
positive
Hearts with
CD45
score ≥ 3
%
positive
p value
1 Control mIgG2a 0/2 0% 0/2 0%
2 anti-Kd mIgG2a 4/7 57 2/7 29 0.048 versus
group 1
3 anti-Kd mIgG2a +
rPSGL-1
0/4 0 0/4 0 0.037 versus
group 2